γH2AX: Applications for the evaluation of telomerase-based cancer therapy

Cell Cycle. 2010 Sep 1;9(17):3385-6. doi: 10.4161/cc.9.17.13003. Epub 2010 Sep 13.

Authors

Asako J Nakamura¹, Christophe E Redon, William M Bonner

Affiliation

¹ Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. nakamuraa@mail.nih.gov

PMID: 20703091
DOI: 10.4161/cc.9.17.13003

No abstract available

Publication types

Editorial

MeSH terms

Apoptosis
DNA Breaks, Double-Stranded
Histones / analysis*
Histones / metabolism
Humans
Neoplasms / drug therapy*
Reactive Oxygen Species / metabolism
Telomerase / antagonists & inhibitors*
Telomerase / chemistry
Telomerase / metabolism

Substances

H2AX protein, human
Histones
Reactive Oxygen Species
Telomerase